A team of researchers at RPI, in collaboration with the University of South Florida, University of North Carolina, and The Neural Stem Cell Institute, have made a discovery that opens the door to new treatments for Alzheimer’s disease and other brain disorders.
RPI Biology Professor Doug Swank, Ph.D., was recently awarded the prestigious Marion J. Siegman Lectureship Award from the American Physiological Society. The award recognizes researchers who have made outstanding contributions to the understanding of muscle contraction and motility.
The Shirley Ann Jackson, Ph.D. Center for Biotechnology and Interdisciplinary Studies (CBIS) at Rensselaer Polytechnic Institute (RPI) was recently awarded $1 million in federal funds as part of the Congressionally Directed Spending program to advance RPI research and translational efforts related to pharmaceuticals, biopolymers, and food production.
Research aims to address a critical bottleneck in the production of mRNA therapeutics.
This semester, the RPI-Mt. Sinai Center for Engineering and Precision Medicine (CEPM) welcomed the inaugural cohort of students in the center’s Ph.D. program in health sciences engineering jointly offered by RPI and Icahn School of Medicine at Mount Sinai.
RPI professor and freshwater ecology expert Kevin Rose, Ph.D., in collaboration with other researchers from Rensselaer Polytechnic Institute (RPI), the Lake George Association (LGA), and Paul Smith’s College, conducted the first ever long-term study on the environmental effects of the aquatic herbicide florpyrauxifen-benzyl (FPB), also known as ProcellaCOR.
The Multi-Organ Approach to Address Diseases Following Estrogen Loss (MODEL) program aims to map the entire biological landscape of menopause
A discovery with major implications for cancer treatment has been made by a team of researchers from Rensselaer Polytechnic Institute (RPI), the University of Nebraska Medical Center (UNMC), University of Binghamton, and SUNY College of Environmental Science and Forestry.